Summary

Description

The Biopharmaceuticals Contract Manufacturing Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Biopharmaceutical contract manufacturing has emerged as a strategic enabler for companies navigating the complexities of biologic and advanced therapy production. With increasing demand for specialized treatments—including monoclonal antibodies, cell therapies, and gene therapies—outsourcing allows firms to focus on core innovation while leveraging scalable, regulatory-compliant infrastructure. CMOs play a critical role in accelerating time-to-market, optimizing costs, and offering technical capabilities often unavailable in-house.

The market is experiencing robust growth, driven by the expanding pipeline of therapies targeting oncology, rare diseases, and autoimmune conditions, alongside a surge in biosimilar development following key patent expirations. Both emerging biotech and large pharmaceutical companies are relying on contract manufacturing to enhance operational agility and manage capital efficiency. The pandemic further underscored the need for resilient and high-capacity manufacturing networks, positioning CMOs as indispensable partners in global healthcare readiness. Technological innovation—ranging from AI-integrated process design to continuous bioprocessing—is enhancing quality and productivity, while the shift toward emerging markets like India and China is fuelled by growing regulatory maturity and cost competitiveness. As the demand for biologics and next-generation therapies accelerates, contract manufacturing will remain a cornerstone of the global biopharmaceutical value chain.

What would be the Impact of US Trade Tariffs on the Global Biopharmaceuticals Contract Manufacturing Market?

The imposition of U.S. trade tariffs on pharmaceutical inputs, biologics, and specialized manufacturing equipment poses significant risks to the global biopharmaceutical contract manufacturing market. These tariffs can disrupt established cost structures and supply chain dynamics by increasing the price of raw materials, reagents, and critical equipment—particularly for CMOs that depend on cross-border sourcing or export to the United States. The resulting production delays and cost inflation may compress profit margins and lead to higher pricing for sponsors, ultimately impacting the affordability of biologics and biosimilars.

However, these trade measures may also act as a catalyst for strategic realignment within the industry. Biopharmaceutical companies could accelerate efforts to diversify their supplier base, localize production, or shift outsourcing to tariff-exempt regions. This shift may stimulate investment in Southeast Asia, India, and select European markets, where regulatory maturity and cost efficiencies align. While U.S.-based CMOs may enjoy a near-term competitive edge in capturing domestic projects, their long-term advantage will depend on sustained policy clarity and scalable infrastructure. In this context, trade tariffs represent a double-edged sword—posing short-term disruption but also creating new opportunities for geographic diversification and operational resilience across the biopharmaceutical manufacturing landscape.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Biopharmaceuticals Contract Manufacturing market evolving?
• What is driving and restraining the Biopharmaceuticals Contract Manufacturing market?
• How will each Biopharmaceuticals Contract Manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each Biopharmaceuticals Contract Manufacturing submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading Biopharmaceuticals Contract Manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Biopharmaceuticals Contract Manufacturing projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of
• Biopharmaceuticals Contract Manufacturing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Biopharmaceuticals Contract Manufacturing market?
• Where is the Biopharmaceuticals Contract Manufacturing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biopharmaceuticals Contract Manufacturing market today, and over the next 10 years:

• Our 376-page report provides 138 tables and 174 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Source

• Mammalian
• Non-mammalian

Service

• Process Development
• Fill & Finish Operations
• Analytical & QC Studies
• Packaging

Product

• Biologics
• Biosimilars

Company Size

• Small
• Mid-sized
• Large

Scale of Operations

• Preclinical
• Clinical
• Commercial

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles for some of the leading companies in the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• AbbVie, Inc.
• AGC Biologics
• Avantor, Inc.
• Binex Co., Ltd.
• Boehringer Ingelheim GmbH
• Cambrex Corporation
• Catalent Inc
• Curia Global, Inc.
• Cytiva
• FUJIFILM Diosynth Biotechnologies
• JRS PHARMA
• Jubilant Pharma Limited
• KBI Biopharma
• Lonza
• Pfizer CentreOne
• ProBioGen
• Rentschler Biopharma SE
• Samsung Biologics
• Sandoz
• TOYOBO CO., LTD.
• Thermo Fisher Scientific

Overall world revenue for Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 in terms of value the market will surpass US$17 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 report help you?

In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Biopharmaceuticals Contract Manufacturing Market 2025 to 2035, with forecasts for source, service, product, company size, and scale of operations, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 26 key national markets – See forecasts for the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 22 of the major companies involved in the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rise in Investment by CMOs for Capacity Expansion
3.3.1.2 Cost and Time Saving Benefits Offered by Contract Services
3.3.1.3 Outsourcing as a Driver for Market Growth
3.3.1.4 Growing Investments in Orphan Drugs
3.3.2 Market Restraining Factors
3.3.2.1 Pricing Pressure to Impede Market Growth
3.3.2.2 Regulatory Scenarios
3.3.2.3 Overcapacity Likely to Challenge Market Growth
3.3.3 Market Opportunities
3.3.3.1 Expansion of Fill and Finish CMOs
3.3.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
3.3.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
3.4 U.S. Tariffs: What’s the Impact on Global Biopharmaceuticals Contract Manufacturing Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.3 Why V-Shaped Recovery?
3.4.3.1 Impact from Tariffs
3.4.3.2 Market Dynamics and Demand Recovery
3.4.3.3 Policy and Funding Support
3.4.3.4 Timeframe for Recovery
3.4.4 U-Shaped Recovery Scenario
3.4.4.1 Why U-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 L Shaped Recovery Scenario
3.4.5.1 Why L-Shaped Recovery?
3.4.5.2 Impact from Tariffs
3.4.5.3 Market Dynamics and Demand Recovery
3.4.5.4 Policy and Funding Support
3.4.5.5 Timeframe for Recovery
3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.4.7 Impact of U.S. and China Trade War on Biopharmaceuticals Contract Manufacturing Market
3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4.9 Sensitivity Mapping for the Trade Tariff Impact
3.5 SWOT Analysis
3.5.1 Strengths
3.5.2 Weaknesses
3.5.3 Opportunities
3.5.4 Threats
3.6 Porter’s Five Forces Analysis
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.7.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market

4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source
4.1 Key Findings
4.2 Source Segment: Market Attractiveness Index
4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
4.4 Mammalian
4.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Non-mammalian
4.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)

5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service
5.1 Key Findings
5.2 Service Segment: Market Attractiveness Index
5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
5.4 Process Development
5.4.1 Upstream Process Development
5.4.2 Downstream Process Development
5.4.3 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
5.4.4 Market Share by Region, 2025 & 2035 (%)
5.5 Fill & Finish Operations
5.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Analytical & QC Studies
5.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Packaging
5.7.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)

6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
6.4 Biologics
6.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Biosimilars
6.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)

7 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size
7.1 Key Findings
7.2 Company Size Segment: Market Attractiveness Index
7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
7.4 Small
7.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Mid-sized
7.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Large
7.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
7.6.2 Market Share by Region, 2025 & 2035 (%)

8 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operations
8.1 Key Findings
8.2 Scale of Operations Segment: Market Attractiveness Index
8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
8.4 Preclinical
8.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Clinical
8.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)
8.6 Commercial
8.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
8.6.2 Market Share by Region, 2025 & 2035 (%)

9 Biopharmaceuticals Contract Manufacturing Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Biopharmaceuticals Contract Manufacturing Market Analysis
10.1 Key Findings
10.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
10.3 North America Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
10.4 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
10.5 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
10.6 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
10.7 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
10.8 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
10.9 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
10.10 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis
10.11 Canada Biopharmaceuticals Contract Manufacturing Market Analysis

11 Europe Biopharmaceuticals Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
11.3 Europe Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
11.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
11.5 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
11.6 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
11.7 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
11.8 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
11.9 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
11.10 Germany Biopharmaceuticals Contract Manufacturing Market Analysis
11.11 UK Biopharmaceuticals Contract Manufacturing Market Analysis
11.12 France Biopharmaceuticals Contract Manufacturing Market Analysis
11.13 Italy Biopharmaceuticals Contract Manufacturing Market Analysis
11.14 Spain Biopharmaceuticals Contract Manufacturing Market Analysis
11.15 Russia Biopharmaceuticals Contract Manufacturing Market Analysis
11.16 Netherlands Biopharmaceuticals Contract Manufacturing Market Analysis
11.17 Switzerland Biopharmaceuticals Contract Manufacturing Market Analysis
11.18 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis

12 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
12.3 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
12.4 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
12.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
12.7 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
12.8 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
12.9 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
12.10 Japan Biopharmaceuticals Contract Manufacturing Market Analysis
12.11 China Biopharmaceuticals Contract Manufacturing Market Analysis
12.12 India Biopharmaceuticals Contract Manufacturing Market Analysis
12.13 Australia Biopharmaceuticals Contract Manufacturing Market Analysis
12.14 South Korea Biopharmaceuticals Contract Manufacturing Market Analysis
12.15 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
12.16 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis

13 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
13.3 Latin America Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
13.4 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
13.5 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
13.6 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
13.7 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
13.8 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
13.9 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
13.10 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis
13.11 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis
13.12 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis
13.13 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis
13.14 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis

14 MEA Biopharmaceuticals Contract Manufacturing Market Analysis
14.1 Key Findings
14.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
14.3 MEA Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
14.4 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
14.5 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
14.6 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
14.7 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
14.8 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
14.9 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
14.10 GCC Biopharmaceuticals Contract Manufacturing Market Analysis
14.11 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis
14.12 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis

15 Company Profiles
15.1 Competitive Landscape
15.2 AbbVie, Inc.
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2021-2024
15.2.3.2 R&D Expenses, 2021-2024
15.2.3.3 Regional Market Shares, 2024
15.2.4 Service Benchmarking
15.2.5 Strategic Outlook
15.3 AGC Biologics
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Service Benchmarking
15.3.4 Strategic Outlook
15.4 Avantor, Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2021-2024
15.4.3.2 Regional Market Shares, 2024
15.4.4 Service Benchmarking
15.4.5 Strategic Outlook
15.5 Binex Co., Ltd.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Service Benchmarking
15.6 Boehringer Ingelheim GmbH
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2021-2024
15.6.4 Service Benchmarking
15.6.5 Strategic Outlook
15.7 FUJIFILM Diosynth Biotechnologies
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Service Benchmarking
15.7.4 Strategic Outlook
15.8 Lonza
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2021-2024
15.8.3.2 R&D Expenses, 2021-2024
15.8.4 Service Benchmarking
15.8.5 Strategic Outlook
15.9 ProBioGen
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Service Benchmarking
15.9.4 Strategic Outlook
15.10 Rentschler Biopharma SE
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Service Benchmarking
15.10.4 Strategic Outlook
15.11 Samsung Biologics
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Service Benchmarking
15.11.4 Strategic Outlook
15.12 Sandoz
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2021-2024
15.12.3.2 Regional Market Shares, 2024
15.12.4 Service Benchmarking
15.12.5 Strategic Outlook
15.13 TOYOBO CO., LTD.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Service Benchmarking
15.14 WuXi Biologics
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2021-2024
15.14.3.2 Regional Market Shares, 2024
15.14.4 Service Benchmarking
15.14.5 Strategic Outlook
15.15 JRS PHARMA
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Service Benchmarking
15.15.4 Strategic Outlook
15.16 Thermo Fisher Scientific
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2021-2024
15.16.3.2 R&D, 2021-2024
15.16.3.3 Regional Market Shares, 2024
15.16.4 Service Benchmarking
15.17 Cambrex Corporation
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Service Benchmarking
15.17.4 Strategic Outlook
15.18 Curia Global, Inc.
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Service Benchmarking
15.18.4 Strategic Outlook
15.19 Pfizer CentreOne
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Financial Analysis
15.19.3.1 Net Revenue, 2021-2024
15.19.3.2 R&D, 2021-2024
15.19.3.3 Regional Market Shares, 2024
15.19.4 Service Benchmarking
15.20 Jubilant Pharma Limited
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Service Benchmarking
15.21 Catalent, Inc
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Financial Analysis
15.21.3.1 Net Revenue, 2021-2024
15.21.4 Service Benchmarking
15.21.5 Strategic Outlook
15.22 KBI Biopharma
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Service Benchmarking
15.22.4 Strategic Outlook
15.23 Cytiva
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Service Benchmarking
15.23.4 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2025 & 2035 (US$ million, CAGR %)
Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 3 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 4 Non-mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 6 Process Development Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Fill & Finish Operations Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Analytical & QC Studies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 11 Biologics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Biosimilars Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 14 Small Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Mid-sized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Large Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 17 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 18 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 22 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 23 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 24 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 25 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 26 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 28 U.S. Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 29 Canada Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 30 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 31 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 32 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 33 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 34 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 36 Germany Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 37 UK Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 38 France Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 39 Italy Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 40 Spain Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 41 Russia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 42 Netherlands Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 43 Switzerland Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 44 Rest of Europe Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 45 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 46 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 47 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 48 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 51 Japan Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 52 China Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 53 India Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 54 Australia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 55 South Korea Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 56 South-East Asia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 57 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 58 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 59 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 60 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 61 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 64 Brazil Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 65 Mexico Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 66 Argentina Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 67 Colombia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 68 Rest of Latin America Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 69 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 70 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 71 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 72 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 75 GCC Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 76 South Africa Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 77 Rest of MEA Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
Table 78 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 AbbVie, Inc.: Service Benchmarking
Table 80 AbbVie, Inc.: Strategic Outlook
Table 81 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 AGC Biologics: Service Benchmarking
Table 83 AGC Biologics: Strategic Outlook
Table 84 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Avantor, Inc.: Service Benchmarking
Table 86 Avantor, Inc.: Strategic Outlook
Table 87 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Binex Co., Ltd.: Service Benchmarking
Table 89 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Boehringer Ingelheim GmbH: Service Benchmarking
Table 91 Boehringer Ingelheim GmbH: Strategic Outlook
Table 92 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 94 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 95 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Lonza: Service Benchmarking
Table 97 Lonza: Strategic Outlook
Table 98 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 ProBioGen: Service Benchmarking
Table 100 ProBioGen: Strategic Outlook
Table 101 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Rentschler Biopharma SE: Service Benchmarking
Table 103 Rentschler Biopharma SE: Strategic Outlook
Table 104 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Samsung Biologics: Service Benchmarking
Table 106 Samsung Biologics: Strategic Outlook
Table 107 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Sandoz: Service Benchmarking
Table 109 Sandoz: Strategic Outlook
Table 110 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 TOYOBO CO., LTD.: Service Benchmarking
Table 112 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 WuXi Biologics: Service Benchmarking
Table 114 WuXi Biologics: Strategic Outlook
Table 115 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 JRS PHARMA: Service Benchmarking
Table 117 JRS PHARMA: Strategic Outlook
Table 118 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Thermo Fisher Scientific: Service Benchmarking
Table 120 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Cambrex Corporation: Service Benchmarking
Table 122 Cambrex Corporation: Strategic Outlook
Table 123 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Curia Global, Inc.: Service Benchmarking
Table 125 Curia Global, Inc.: Strategic Outlook
Table 126 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Pfizer CentreOne: Service Benchmarking
Table 128 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Jubilant Pharma Limited: Service Benchmarking
Table 130 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Catalent, Inc: Service Benchmarking
Table 132 Catalent, Inc: Strategic Outlook
Table 133 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 KBI Biopharma: Service Benchmarking
Table 135 KBI Biopharma: Strategic Outlook
Table 136 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Cytiva: Service Benchmarking
Table 138 Cytiva: Strategic Outlook
 
List of Figures
Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
Figure 2 Biopharmaceuticals Contract Manufacturing Market by Source: Market Attractiveness Index
Figure 3 Biopharmaceuticals Contract Manufacturing Market by Service: Market Attractiveness Index
Figure 4 Biopharmaceuticals Contract Manufacturing Market by Product: Market Attractiveness Index
Figure 5 Biopharmaceuticals Contract Manufacturing Market by Company Size: Market Attractiveness Index
Figure 6 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations: Market Attractiveness Index
Figure 7 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Region
Figure 8 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
Figure 9 Biopharmaceuticals Contract Manufacturing Market: Impact Analysis
Figure 10 SWOT Analysis
Figure 11 Porter’s Five Forces Analysis
Figure 12 PEST Analysis
Figure 13 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 14 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 15 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025, 2030, 2035 (%)
Figure 16 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 17 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Non-mammalian Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 19 Non-mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 21 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 22 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025, 2030, 2035 (%)
Figure 23 Process Development Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 24 Process Development Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Fill & Finish Operations Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 26 Fill & Finish Operations Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Analytical & QC Studies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 28 Analytical & QC Studies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 30 Packaging Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
Figure 32 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 33 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 34 Biologics Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 35 Biologics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 36 Biosimilars Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 37 Biosimilars Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
Figure 39 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 40 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025, 2030, 2035 (%)
Figure 41 Small Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 42 Small Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 43 Mid-sized Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 44 Mid-sized Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Large Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 46 Large Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operations
Figure 48 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 49 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025, 2030, 2035 (%)
Figure 50 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 51 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 52 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 53 Clinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 55 Commercial Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 57 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 58 Biopharmaceuticals Contract Manufacturing Market by Region, 2025-2035 (US$ Mn)
Figure 59 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 60 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 61 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 62 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 63 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 64 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
Figure 65 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 66 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
Figure 67 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
Figure 69 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 72 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
Figure 73 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 74 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 75 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 76 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 77 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 78 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 79 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 80 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
Figure 81 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 82 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
Figure 83 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 84 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
Figure 85 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
Figure 87 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 88 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
Figure 89 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 90 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 91 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 92 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 93 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 94 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 95 Netherlands Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 96 Switzerland Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 97 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 98 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 99 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 100 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 101 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 102 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 103 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
Figure 104 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 105 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
Figure 106 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 107 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
Figure 108 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 109 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
Figure 110 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 111 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
Figure 112 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 113 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 114 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 115 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 116 South Korea Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 117 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 118 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 119 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 120 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 121 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 122 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 123 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 124 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
Figure 125 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 126 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
Figure 127 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 128 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
Figure 129 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 130 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
Figure 131 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 132 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
Figure 133 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 134 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 135 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 136 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 137 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 138 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 139 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 140 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 141 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 142 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
Figure 143 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
Figure 144 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
Figure 145 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
Figure 146 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
Figure 147 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
Figure 148 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
Figure 149 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
Figure 150 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
Figure 151 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
Figure 152 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 153 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 154 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 155 Biopharmaceuticals Contract Manufacturing Market: Company Share/Ranking
Figure 156 AbbVie, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 157 AbbVie, Inc.: R&D Expenses, 2021-2024 (US$ Million, AGR %)
Figure 158 AbbVie, Inc.: Regional Market Shares, 2024 (%)
Figure 159 Avantor, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 160 Avantor, Inc.: Regional Market Share (%)
Figure 161 Boehringer Ingelheim GmbH: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 162 Lonza: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 163 Lonza: R&D Expenses, 2021-2024 (US$ Million, AGR %)
Figure 164 Sandoz: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 165 Sandoz: Regional Market Share (%)
Figure 166 WuXi Biologics: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 167 WuXi Biologics: Regional Market Shares, 2024 (%)
Figure 168 Thermo Fisher Scientific: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 169 Thermo Fisher Scientific: R&D, 2021-2024 (US$ Million, AGR %)
Figure 170 Thermo Fisher Scientific: Regional Market Shares, 2024 (%)
Figure 171 Pfizer CentreOne: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 172 Pfizer CentreOne: R&D, 2021-2024 (US$ Million, AGR %)
Figure 173 Pfizer CentreOne: Regional Market Shares, 2024 (%)
Figure 174 Catalent, Inc: Net Revenue, 2021-2024 (US$ Million, AGR %)